Infectious Agents and Cancer

SJR Rank #5,584H-index: 54SJR: 0.920Best quartile: Q2Open AccessAPC: US$3,190Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

BioMed Central Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • EpidemiologyQ2
  • Infectious DiseasesQ2
  • OncologyQ2
  • Cancer ResearchQ3

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Cervical Cancer and HPV ResearchViral-associated cancers and disordersHead and Neck Cancer StudiesLymphoma Diagnosis and TreatmentReproductive tract infections researchHepatitis B Virus StudiesCytomegalovirus and herpesvirus researchEndometrial and Cervical Cancer TreatmentsHepatitis C virus researchWomen's cancer prevention and management

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs055110165220

Documents per Year

202220250255075100

Detailed Information

ISSN

1750-9378

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

3.17

References per Document

59.58

Coverage

2006-2026

Scope

Infectious Agents and Cancer is an open access, peer-reviewed online journal that encompasses all aspects of basic, clinical, epidemiological and translational research providing an insight into the association between chronic infections and cancer. The journal welcomes submissions in the pathogen-related cancer areas and other related topics, in particular: • HPV and anogenital cancers, as well as head and neck cancers; • EBV and Burkitt lymphoma; • HCV/HBV and hepatocellular carcinoma as well as lymphoproliferative diseases; • HHV8 and Kaposi sarcoma; • HTLV and leukemia; • Cancers in Low- and Middle-income countries. The link between infection and cancer has become well established over the past 50 years, and infection-associated cancer contribute up to 16% of cancers in developed countries and 33% in less developed countries. Preventive vaccines have been developed for only two cancer-causing viruses, highlighting both the opportunity to prevent infection-associated cancers by vaccination and the gaps that remain before vaccines can be developed for other cancer-causing agents. These gaps are due to incomplete understanding of the basic biology, natural history, epidemiology of many of the pathogens that cause cancer, the mechanisms they exploit to cause cancer, and how to interrupt progression to cancer in human populations. Early diagnosis or identification of lesions at high risk of progression represent the current most critical research area of the field supported by recent advances in genomics and proteomics technologies.

Metrics from SCImago Journal Rank 2025. View on SCImago